Intensity Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: INTS · Form: 8-K · Filed: Jul 18, 2025 · CIK: 1567264
| Field | Detail |
|---|---|
| Company | Intensity Therapeutics, Inc. (INTS) |
| Form Type | 8-K |
| Filed Date | Jul 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance, disclosure
TL;DR
Intensity Therapeutics filed an 8-K for a shareholder vote on July 17th.
AI Summary
Intensity Therapeutics, Inc. filed an 8-K on July 18, 2025, reporting on a submission of matters to a vote of security holders that occurred on July 17, 2025. The company, incorporated in Delaware, is involved in biological products and is headquartered in Shelton, CT.
Why It Matters
This filing indicates a formal process where security holders are being asked to vote on specific company matters, which could impact corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Numbers
- 001-41109 — SEC File Number (Identifies the company's filing history with the SEC.)
- 46-1488089 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- INTENSITY THERAPEUTICS, INC. (company) — Registrant
- July 17, 2025 (date) — Date of earliest event reported
- July 18, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Shelton, CT (location) — Principal Executive Offices
FAQ
What specific matters were submitted for a vote of security holders on July 17, 2025?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Intensity Therapeutics, Inc.?
Intensity Therapeutics, Inc. is involved in Biological Products (No Diagnostic Substances), as indicated by its SIC code 2836.
When was the company incorporated?
The company was incorporated in Delaware.
What is the address of Intensity Therapeutics' principal executive offices?
The principal executive offices are located at 1 Enterprise Drive, Suite 430, Shelton, CT 06484-4779.
Is this the first 8-K filing for Intensity Therapeutics?
The filing number 001-41109 suggests a history of filings, and the presence of a former company name and date of name change indicates prior corporate activity.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 18, 2025 regarding INTENSITY THERAPEUTICS, INC. (INTS).